Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association

Cited by (1,000)

Items 601–700 of 1,000

1. Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction
   Micha Tobias Maeder, Lukas Weber, Marc Buser, Roman Brenner, Lucas Joerg, Hans Rickli · 2021 · Frontiers in Cardiovascular Medicine
2. Assessment of Physical Activity Using Waist-Worn Accelerometers in Hospitalized Heart Failure Patients and Its Relationship with Kansas City Cardiomyopathy Questionnaire
   Yasuyuki Shiraishi, Nozomi Niimi, Ayumi Goda, Makoto Takei, Takehiro Kimura, Takashi Kohno, Masataka Kawana, Keiichi Fukuda, Shun Kohsaka · 2021 · Journal of Clinical Medicine
3. Cardiogenic shock centres for optimal care coordination and improving outcomes in cardiogenic shock
   Ovidiu Chioncel, Marco Metra · 2021 · European Journal of Heart Failure
4. ‘Peptide for Life’ in primary care: work in progress
   Antoni Bayés‐Genís, Andrew J.S. Coats · 2021 · European Heart Journal
5. Cardiometabolic Phenotype in HFpEF: Insights from Murine Models
   Ekaterina Ogurtsova, Tatiana I. Arefieva, A. Yu. Filatova, N. V. Radyukhina, Artem G. Ovchinnikov · 2025 · Biomedicines
6. Acoustic Features are Independently Associated with Heart Failure and Pulmonary Hypertension
   Jaskanwal Deep Singh Sara, Keiko Ishikawa, Yan Li, DM Anisuzzaman, Lilach O. Lerman, Amir Lerman, Diana M. Orbelo · 2025 · ESC Heart Failure
7. Prognostic Impact of Fibroblast Growth Factor 21 in Patients With Heart Failure
   Hiroaki Sunaga, Kuniko Yoshida, Kazuki Kagami, Tomonari Harada, Tsukasa Murakami, Naoki Yuasa, Hiroki Matsui, Keiko Kawai‐Kowase, Tatsuya Iso, Tomoyuki Yokoyama et al. · 2025 · Circulation Reports
8. Cardiometabolic Outcomes with Dapagliflozin After Myocardial Infarction by Baseline Ejection Fraction: DAPA-MI
   David Erlinge, Stefan Karl James, John Eric Deanfield, Niclas Eriksson, Mark de Belder, Monér Alchay, David Austin, Daniel A. Jones, Annica Ravn‐Fischer, Sofia Sederholm Lawesson et al. · 2025 · ESC Heart Failure
9. Comprehensive Profiling Identifies Circulating microRNA Dysregulation in Vietnamese Patients with Heart Failure
   Bao-Quoc Vu, Phuong Anh Huynh, N. Nguyen, Niệm Văn Thành Võ, Linh Gia Hoang Le, Vũ Hoàng Vũ, Thanh Cong Nguyen, Minh Hoang, Diem My Vu · 2025 · International Journal of Molecular Sciences
10. Future Development of Arrhythmogenic Risk Scores in Patients with Heart Failure and Inherited Dilated Cardiomyopathy. A Scientific Statement of the Heart Failure Association of the ESC
    Marta Gigli, Job A.J. Verdonschot, Pablo García‐Pavía, Davide Stolfo, Lorenzo Monserrat, Sanjay Kumar Prasad, Andrea Mazzanti, Folkert Wouter Asselbergs, Barbara Bauce, Philippe Charron et al. · 2025 · European Journal of Heart Failure
11. Efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a meta-analysis of randomized controlled trials
    Jinfei Wu, Yi-Bin Pei, Junqing Wu, Yongfang Huang · 2025 · BMC Cardiovascular Disorders
12. Gut Microbiota Alterations in Heart Failure Patients: Insights from a Systematic Review
    Néstor Báez‐Ferrer, Alejandro Lemus-Martín, María Beatriz Castro-Hernández, Pablo Avanzas y, Susana Martínez González, María Lecuona, Alberto Domínguez‐Rodríguez · 2025 · Journal of Clinical Medicine
13. The Role of MicroRNAs in the Pathophysiology and Management of Heart Failure: From Molecular Mechanisms to Clinical Application
    I. R. Gilyazova, Yanina Timasheva, A.O. Chumakova, Gulshat Abdeeva, Marina Plotnikova, Naufal Sh. Zagidullin · 2025 · International Journal of Molecular Sciences
14. Reverse Remodelling, Myocardial Recovery and Remission in Heart Failure with Reduced Ejection Fraction: Clinical Implications and Management Strategies
    Silas Ramos Furquim, Maria Tereza Sampaio de Sousa Lira, Deborah de Sá Pereira Belfort, Bruno Biselli, Paulo Roberto Chizzola, Robinson Tadeu Munhoz, Edimar Alcides Bocchi, Silvia Moreira Ayub-Ferreira · 2025 · Cardiac failure review
15. Addressing Unmet Needs in Heart Failure with Preserved Ejection Fraction: Multi-Omics Approaches to Therapeutic Discovery
    Taemin Kim, Michael Sheen, Daniel Ryan, Jacob Joseph · 2026 · International Journal of Molecular Sciences
16. Cardiac Congestion Assessed by Natriuretic Peptides Oversimplifies the Definition and Treatment of Heart Failure
    Alberto Palazzuoli, Wilfried Müllens · 2021 · ESC Heart Failure
17. Implantation mechanischer Unterstützungssysteme und Herztransplantation bei Patienten mit terminaler Herzinsuffizienz
    Paul Christian Schulze, Markus Johannes Barten, Udo Boeken, Gloria Färber, Christian M. Hagl, Christian Jung, David M. Leistner, Evgenij V Potapov, Johann K Bauersachs, Philip W J Raake et al. · 2022 · Die Kardiologie
18. Undernutrition was a prevalent clinical problem among older adult patients with heart failure in a hospital setting in Northwest Ethiopia
    Hussen Ahmed, Abilo Tadesse, Hailemaryam Alemu, Alula Abebe, Melaku Tadesse · 2022 · Frontiers in Nutrition
19. The clinical significance of circulating glucose-regulated protein 78, Caspase-3, and C/EBP homologous protein levels in patients with heart failure
    Xuecheng Zhao, Daqi Zhang, Rongjing Song, Rong Wang, Guoqiang Zhang · 2023 · Heliyon
20. Retrospective comparison of traditional and artificial intelligence-based heart failure phenotyping in a US health system to enable real-world evidence
    Arthur Reshad Garan, Keri L. Monda, Ricardo E. Dent-Acosta, Daniel J. Riskin, Ty J. Gluckman · 2023 · BMJ Open
21. Prognostic Value of Baseline Echocardiographic Parameters in Heart Failure With Improved vs Nonrecovered Ejection Fraction
    Gusti Ngurah Prana Jagannatha, Luh Oliva Saraswati Suastika, Anastasya Maria Kosasih, Bryan Gervais de Liyis, Mirani Ulfa Yusrika, Stanly Kamardi, Jonathan Adrian, I Wayan Agus Surya Pradnyana, Alif Hakim Alamsyah, Yosep Made Pius Cardia et al. · 2023 · CJC Open
22. Volume markers in left ventricular diastolic dysfunction and adverse outcomes in peritoneal dialysis patients: a prospective cohort study
    Shoubo Xiang, Mingliang Zuo, Yan Deng, Xian Luo, Qianhua Dong, Jin Chen, Chung‐Wah Siu, Lixue Yin · 2023 · Scientific Reports
23. Cardiac autonomic dysfunction in adult congenital heart disease
    Carmen Pizarro, Franziska Luise Bosse, Charlotte Begrich, Barbora Reznakova, Thomas Beiert, JAN WILKO SCHRICKEL, Georg Nickenig, Dirk Skowasch, Diana Momčilović · 2023 · BMC Cardiovascular Disorders
24. Pulse wave-based evaluation of the blood-supply capability of patients with heart failure via machine learning
    Sirui Wang, Ryohei Ono, Dandan Wu, Kaoruko Aoki, Hirotoshi Kato, Togo Iwahana, Sho Okada, Yoshio Kobayashi, Hao Liu · 2024 · BioMedical Engineering OnLine
25. Development and Validation of the Self-Volume Management Behaviour Questionnaire for Patients with Chronic Heart Failure
    Zhenlan Luo, Tiantian Ruan, Mengqi Xu, Yuan Ding, Lingyan Zhu · 2024 · ESC Heart Failure
26. Heart Failure with Mildly Reduced Ejection Fraction—A Phenotype Waiting to Be Explored
    Anugrah Nair, Lukah Q. Tuan, Natasha Jones-Lewis, Deep Chandh Raja, Jenish P. Shroff, Rajeev Kumar Pathak · 2024 · Journal of Cardiovascular Development and Disease
27. Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction
    Filippo Maria Sarullo, Cinzia Nugara, Silvia Sarullo, Massimo Iacoviello, Gabriele Di Gesaro, Daniela Miani, Mauro Driussi, Michele Correale, Claudio Bilato, Andrea Passantino et al. · 2024 · Frontiers in Cardiovascular Medicine
28. Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophy
    Marianela Schiava, Robert Muni‐Lofra, John P. Bourke, Meredith K. James, Jordi Díaz‐Manera, Maha A. Elseed, Jassi Michell-Sodhi, Dionne Moat, Michelle McCallum, Anna G Mayhew et al. · 2024 · Neuromuscular Disorders
29. Prognostic Impact of New-Onset Atrial Fibrillation in Myocardial Infarction with and Without Improved Ejection Fraction
    Jiachen Luo, Xiaoming Qin, Xingxu Zhang, Yiwei Zhang, Yuan Fang, Wentao Shi, Baoxin Liu, Yidong Wei, the NOAFCAMI-SH Registry Investigators · 2024 · ESC Heart Failure
30. Obesity and 1-year all-cause survival of adult intensive care patients with heart failure: data from the MIMIC-IV.
    Fei Xu, Cheng Zhang · 2024 · Diabetology & Metabolic Syndrome
31. Sex-related differences in self-efficacy in patients with heart failure: a pooled cross-sectional study of the German Competence Network Heart Failure
    Fabian Kerwagen, Floran Sahiti, Judith Albert, Maximilian Bauser, Caroline Morbach, Gülmisal Güder, Stefan Frantz, Anna Strömberg, Sebastian Kerber, Brigitte Gebhard et al. · 2024 · European Journal of Cardiovascular Nursing
32. Inhibition of Myeloperoxidase to Treat Left Ventricular Dysfunction in Non-Ischaemic Cardiomyopathy
    Simon Geißen, Simon Braumann, Joana Adler, Felix Sebastian Nettersheim, Dennis Mehrkens, Alexander Hof, Henning Guthoff, Philipp von Stein, Sven Witkowski, Norbert Gerdes et al. · 2024 · European Journal of Heart Failure
33. Characteristics and Outcomes of Heart Failure in Japan: A Hospital-Based Administrative Database Analysis
    Yasuhisa Ono, Kazuhiro Yoneda, Naoki Okuyama, Toshiyuki Nagai · 2024 · ESC Heart Failure
34. The Effect of Heart Failure Symptom Clusters on Quality of Life: The Moderating Effect of Self‐Care Behaviours
    Qian Yao, Jian Luo, Baomei Song, Jin Yang, Xiaorong Yuan, Xiuchuan Li, Wei Tian, Tianyi Wang, Bin Zhu, Zheng Yang · 2024 · Journal of Clinical Nursing
35. Spectrum of hereditary transthyretin amyloidosis due to T60A(p.Thr80Ala) variant in an Irish Amyloidosis Network
    Katie Hewitt, Neasa Starr, Zara Togher, Saadah Sulong, Joseph Morris, Michael D. Alexander, Mark Coyne, Katie Murphy, Gerard T. Giblin, Sinéad M. Murphy et al. · 2024 · Open Heart
36. Loss of Trim31 Worsens Cardiac Remodeling in a Mouse Model of Heart Failure by Enhancing the Activation of the NLRP3 Inflammasome
    Fengqi Duan, H. Li, Bo Lu, Xiaobo Wang, Xiaojun Xu · 2024 · Inflammation
37. Collaboration between dyspnea clinic and primary care physicians to identify heart failure with preserved ejection fraction in the community: Results from the Maebashi City HF project
    Naoki Yuasa, Satoshi Ubukata, Ryo Takayanagi, Eiji Yamashita, Keiji Hoshino, Yuta Tani, Takashi Kawashima, Hideki Ishii, Masaru Obokata · 2025 · Journal of Cardiology
38. Advanced point-of-care biomarker testing for the diagnosis of cardiovascular diseases
    Wenjun Ming, Yidan Zhu, Wenjun Jiang, Jing Zhang, Jinxia Liu, Li Wu, Yuling Qin · 2025 · Sensing and Bio-Sensing Research
39. Hospital Variability in the Use of Vasoactive Agents in Patients Hospitalized for Acute Decompensated Heart Failure for Clinical Phenotypes
    Yasuyuki Shiraishi, Nozomi Niimi, Shun Kohsaka, Kazumasa Harada, Takashi Kohno, Makoto Takei, Takahiro Jimba, Hiroki Nakano, Junya Matsuda, Akito Shindo et al. · 2025 · Circulation Cardiovascular Quality and Outcomes
40. The prognostic value of the Braden scale on all-cause death in older patients with heart failure in the intensive care unit: a cohort study
    J. Zhu, Hui Pan, Zhi‐Cheng Yang, Guihua Jiang, Zhihao Wang · 2025 · European Journal of Cardiovascular Nursing
41. Heart failure in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III
    Bernadette Corica, Giulio Francesco Romiti, Marco Proietti, Giuseppe Boriani, Brian Olshansky, Menno Volkert Huisman, Gregory Y.H. Lip · 2025 · European Journal of Preventive Cardiology
42. Why we love heart failure: an introduction to the universal definition of heart failure
    Marco Metra, Andrew J.S. Coats · 2021 · European Journal of Heart Failure
43. Newly Diagnosed Atrial Fibrillation and Hospital Utilization in Heart Failure: A Nationwide Cohort Study
    Nicklas Vinter, Pia Cordsen, Gregory Y.H. Lip, Emelia J. Benjamin, Ludovic Trinquart, Søren Paaske Johnsen, Lars Frost · 2021 · ESC Heart Failure
44. Nitrogen dioxide component of air pollution increases pulmonary congestion assessed by lung ultrasound in patients with chronic coronary syndromes
    Quirino Ciampi, Antonello Russo, Caterina D’Alise, Anna Ballirano, Bruno Villari, Cristina Mangia, Eugenio Picano, the Stress Echo 2030 study group of the Italian Society of Echocardiography, Cardiovascular Imaging · 2021 · Environmental Science and Pollution Research
45. Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type 2 diabetes mellitus without known cardiovascular disease
    Shota Ikeda, Keisuke Shinohara, Nobuyuki Enzan, Shouji Matsushima, Takeshi Tohyama, Kouta Funakoshi, Junji Kishimoto, Hiroshi Itoh, Issei Komuro, Hiroyuki Tsutsui · 2022 · International Journal of Cardiology
46. Prognostic utility of the prognostic nutritional index combined with serum sodium level in patients with heart failure
    Lang Zhao, Xuemei Zhao, Pengchao Tian, Lin Liang, Boping Huang, Liyan Huang, Jiayu Feng, Yuhui Zhang, Jian Zhang · 2022 · Nutrition Metabolism and Cardiovascular Diseases
47. Clinical predictors of improvement in left ventricular ejection fraction in U.S. veterans with heart failure
    Shriram Nallamshetty, Adrian Castillo, Andrew Nguyen, François Haddad, Paul A. Heidenreich · 2022 · American Heart Journal Plus Cardiology Research and Practice
48. Emerging Treatment Approaches to Improve Outcomes in Patients with Heart Failure
    Barry Greenberg · 2022 · Cardiology Discovery
49. NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients
    Patrick Rossignol, Kévin Duarte, Emmanuel Bresso, Anders Åsberg, Marie‐Dominique Devignes, Niclas Eriksson, Nicolas Girerd, Rie Io Glerup, Alan G. Jardine, Hallvard Holdaas et al. · 2022 · European Heart Journal Open
50. APELIN IN HEART FAILURE
    Kamil Piotr Marczewski, Natalia Justyna Gospodarczyk, Alicja Zofia Gospodarczyk, Michał Widuch, Michał T Tkocz · 2022 · Wiadomości Lekarskie
51. Chronic heart failure: the role of di vericiguat
    Giuseppe Caminiti, Barbara Sposato, Maurizio Volterrani · 2023 · European Heart Journal Supplements
52. Improvement of exercise and functional capacity and quality of life in patients with heart failure by iron therapy
    Andrea Simone Deichl, Frank Edelmann · 2023 · Frontiers in Cardiovascular Medicine
53. Noncardiovascular morbidity and mortality across left ventricular ejection fraction categories following hospitalization for heart failure
    Enrique Santas, Pau Llàcer, Patricia Palau, Rafael de la Espriella, Gema Miñana, Miguel Lorenzo, Gonzalo Núñez‐Marín, Òscar Miró, F. Javier Chorro, Antoni Bayés‐Genís et al. · 2023 · Revista Española de Cardiología (English Edition)
54. The E/e′ ratio on echocardiography as an independent predictor of the improvement of left ventricular contraction in patients with heart failure with reduced ejection fraction
    Ryutaro Yoshimura, Ou Hayashi, Takeshi Horio, Ryosuke Fujiwara, Yujiro Matsuoka, Go Yokouchi, Yuya Sakamoto, Naoki Matsumoto, Kohei Fukuda, Masahiro Shimizu et al. · 2023 · Journal of Clinical Ultrasound
55. Telmisartan versus EnalapRil In heart failure with redUced ejection fraction patients with Moderately impaired kidney Functions; randomized controlled trial: “TRIUMF trial”
    Ahmad Samir, Salma Aboel-Naga, Ahmed Shehata, Magdy Abdelhamid · 2023 · The Egyptian Heart Journal
56. Left Ventricular End-Systolic Diameter May Predict Persistent Heart Failure with Reduced Ejection Fraction
    Takuma Takada, Yuki Nakata, Katsuhisa Matsuura, Yuichiro Minami, Makoto Kishihara, Shonosuke Watanabe, Shota Shirotani, Takuro Abe, Ayano Yoshida, Shun Hasegawa et al. · 2023 · International Heart Journal
57. Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 Diabetes
    Emer M. Brady, Thong Huy Cao, Alastair James Moss, Lavanya Athithan, Sarah L Ayton, Emma L. Redman, Stavroula Argyridou, Matthew P. M. Graham-Brown, Colleen B. Maxwell, Donald J. L. Jones et al. · 2024 · BMC Cardiovascular Disorders
58. Potential regulatory role of epigenetic modifications in aging-related heart failure
    Lin Lv, Qiuyu Chen, Jing Lü, Qi Zhao, Hongyan Wang, Jiahao Li, Keying Yuan, Zengxiang Dong · 2024 · International Journal of Cardiology
59. Clinical Perspective of Myocardial Recovery and Improvement: Definitions, Prevalence, and Relevance
    Anthony V. Pensa, Veronica J. Zheng, Lucia Davis, Rebecca Harap, Jane E. Wilcox · 2024 · Methodist DeBakey Cardiovascular Journal
60. Continuous Intravenous Inotropic Support for Advanced Heart Failure: Palliative Considerations
    Alexandra L. McPherson, Cindy Nguyen, Hunter Groninger, Kelley M. Anderson, Paul R. Henderson, Anirudh Rao · 2022 · Journal of Pain & Palliative Care Pharmacotherapy
61. The prognosis and therapeutic management of patients hospitalized for heart failure in 2010-2020
    Otto Mayer, Jan Bruthans, Simona Bílková, Jitka Seidlerová, Josef Jirák, Jan Filipovský · 2022 · Biomedical Papers
62. Associations of short‐ and long‐term mortality with admission blood pressure in Chinese patients with different heart failure subtypes
    Shilan Chen, Weihao Liang, Yuzhong Wu, Xuwei Chen, Xin He, Jingjing Zhao, Jiangui He, Yugang Dong, Jan Albert Staessen, Chen Liu et al. · 2022 · Journal of Clinical Hypertension
63. Updates in heart failure: sodium glucose co-transporter 2 inhibitors and beyond – major changes are coming
    Giuliana Cimino, Edoardo Pancaldi, Daniela Tomasoni, Carlo Lombardi, Marco Metra, Marianna Adamo · 2022 · Journal of Cardiovascular Medicine
64. Management of heart failure: similarities and discrepancies between the European Society of Cardiology and the American Heart Association guidelines
    Antonio Luca Maria Parlati, Christian Basile, Pasquale Perrone Filardi · 2023 · European Heart Journal Supplements
65. Morbimortalidad no cardiovascular en función de la fracción de eyección del ventrículo izquierdo tras una hospitalización por insuficiencia cardiaca
    Enrique Santas, Pau Llàcer, Patricia Palau, Rafael de la Espriella, Gema Miñana, Miguel Lorenzo, Gonzalo Núñez‐Marín, Òscar Miró, F. Javier Chorro, Antoni Bayés‐Genís et al. · 2023 · Revista Española de Cardiología
66. Posicionamiento SEMERGEN en el abordaje de la insuficiencia cardíaca crónica en atención primaria
    María José Castillo Moraga, Miguel Turégano-Yedro, Vicente Pallarés‐Carratalá, M.C. Seoane-Vicente, Adalberto Serrano Cumplido, Antonio Ruiz‐García, E. Martin-Rioobó, Carlos Escobar-Cervantes, José Polo García, Vivencio Barrios · 2021 · Medicina de Familia SEMERGEN
67. Identifying Heart Failure from Electronic Health Records: A Systematic Evidence Review
    Rebecca T. Levinson, Jennifer R. Malinowski, Suzette J. Bielinski, Luke V. Rasmussen, Melissa P. Wilson, Sheila M. Manemann, Quinn Stanton Wells, Veronique Lee Roger, Laura K. Wiley · 2021 · medRxiv
68. Effects of orientation of myocardial fibers on the contractility of left ventricle
    Peijin Li, Anqiang Sun, Caixia Guo, Zhilong Peng, Chao Wang · 2025 · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials
69. Implications of HFpEF Definitions Unveiled by Rest and Exercise Hemodynamics
    Isabela Landsteiner, Takenori Ikoma, Ashvita Ramesh, Joseph Campain, LAURA P. COHEN, Charles Corey Hardin, Rajeev Kumar Malhotra, Gregory D. Lewis · 2025 · Circulation Research
70. Contemporary Implementation of Guideline-Directed Medical and Device Therapies in Heart Failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey
    Petar M Seferovic, Marija M. Polovina, Jan Krejčí, Béla Péter Merkely, Mariya Petkova Tokmakova, Martin Huelssmann, Vladimir Miloradović, Svetlana R. Apostolovic, Elizabeta Srbinovska‐Kostovska, Slavica Radovanović et al. · 2025 · European Journal of Heart Failure
71. Prognostic Value of Natriuretic Peptide Levels in Heart Failure With Recovered Ejection Fraction
    Nandan Kodur, Paul R. Gunsalus, Alex Milinovich, Jarrod E. Dalton, W.H. Wilson Tang · 2025 · Circulation Heart Failure
72. PhenoFit: a framework for determining computable phenotyping algorithm fitness for purpose and reuse
    Laura K. Wiley, Luke V. Rasmussen, Rebecca T. Levinson, Jennifer R. Malinowski, Sheila M. Manemann, Melissa P. Wilson, Martin Chapman, Jennifer A. Pacheco, Theresa L. Walunas, Justin B. Starren et al. · 2025 · Journal of the American Medical Informatics Association
73. A contemporary review on heart failure with improved ejection fraction
    Allison Weiss, Ambre Flowers, Scott D. Eisenberg, Lingling Wu, Mario Rodríguez Rodríguez, Muzamil Khawaja, Errol Moras, Carl J. Lavie, Gregg C. Fonarow, W.H. Wilson Tang et al. · 2025 · npj Cardiovascular Health
74. Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
    Tatjana Cvetković, Sandra Šarić, NIKOLA Z. STEFANOVIĆ, Vladana Stojiljković, Branka Djordjevic, Dijana R. Stojanović, Mina Cvetković, Marina Deljanin Ilic · 2022 · Journal of International Medical Research
75. Associations of long-term mortality with serum uric acid at admission in acute decompensated heart failure with different phenotypes
    Fang‐Fei Wei, Xuwei Chen, Winglam Cheng, Shilan Chen, Yuzhong Wu, Zhongping Yu, Jiale Huang, Jingjing Zhao, Jiangui He, Nicholas Cauwenberghs et al. · 2023 · Nutrition Metabolism and Cardiovascular Diseases
76. Heart Failure in Elderly People: From Pathophysiology to Diagnosis and Management
    Elisa Martinelli, Angelo Di Stefano, Pietro Gareri, Pasqualina Sapone, Rosaria Carlucci, Massimo Brandino, Ettore Maina, Sara Piscioneri, Giada Cagnoli, Antonino Maria Cotroneo · 2023 · OBM Geriatrics
77. The value of using left ventricular pressure-strain loops to evaluate myocardial work in predicting heart failure with improved ejection fraction
    Tianyue Li, Ziyao Li, Shuang Guo, Shuangquan Jiang, Qinliang Sun, Yan Xiang Wu, Jiawei Tian · 2023 · International Journal of Cardiology
78. Clinical Implication of Supra-Normal Left Ventricular Ejection Fraction in Patients Undergoing Transcatheter Aortic Valve Replacement
    Teruhiko Imamura, Yuki Hida, Hiroshi Ueno, Koichiro Kinugawa, Fumiaki Yashima, Norio Tada, Masahiro Yamawaki, Shinichi Shirai, Toru Naganuma, Futoshi Yamanaka et al. · 2023 · Journal of Clinical Medicine
79. A nationwide trend analysis on the usage of endomyocardial biopsy
    Karsten Keller, Sebastian Göbel, Tommaso Gori, Thomas F. Münzel, Philip Wenzel, Lukas Hobohm · 2023 · Clinical Cardiology
80. 2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction.
    Yi‐Heng Li, Chun‐Chieh Wang, Chung‐Lieh Hung, Yen‐Wen Wu, Chih‐Hsin Hsu, Yi‐Liang Tsou, Chao‐Hung Wang, Cho‐Kai Wu, Po‐Lin Lin, Hung‐Yu Chang et al. · 2024 · PubMed Central
81. Quality of heart failure registration in primary care: observations from 1 million electronic health records in the Amsterdam Metropolitan Area
    Lukas De Clercq, Jelle C L Himmelreich, Ralf E. Harskamp · 2024 · Diagnosis
82. Integrated biomarker profiling for enhanced heart failure management: a comprehensive study on the application of chemiluminescence detection of GDF-15 and multi-index models
    Ju Zhang, Jiajia Zhang, Cheng-Yi Huang, Ting Wu, Peipei Jin · 2024 · Laboratory Medicine
83. The roles of exercise stress echocardiography for the evaluation of heart failure with preserved ejection fraction in the heart failure pandemic era
    Naoki Yuasa, Tomonari Harada, Kazuki Kagami, Hideki Ishii, Masaru Obokata · 2024 · Journal of Medical Ultrasonics
84. Screening for Heart Failure: Biomarkers to Detect Heightened Risk in the General Population
    Leah B. Kosyakovsky, Rudolf A. de Boer, Jennifer E. Ho · 2024 · Current Heart Failure Reports
85. Cardiovascular outcomes in Parkinson’s disease patients from a retrospective cohort study
    Subin Lim, Yunjin Yum, Jong-Ho Kim, Chan‐Nyoung Lee, Hyung Joon Joo, Do-Young Kwon · 2024 · Scientific Reports
86. The Role of NAD+ Metabolism in Cardiovascular Diseases: Mechanisms and Prospects
    Huimin Li, Qingxun Hu, Deqiu Zhu, Dan Wu · 2024 · American Journal of Cardiovascular Drugs
87. Early Genetic Screening and Cardiac Intervention in Patients with Cardiomyopathies in a Multidisciplinary Clinic
    Chandu Sadasivan, Luke R. Gagnon, Deepan Hazra, Kaiming Wang, Erik R. E. Youngson, Jissy Thomas, Anita Y.M. Chan, D. Ian Paterson, Finlay Aleck McAlister, Tara Dzwiniel et al. · 2024 · ESC Heart Failure
88. Analytical characteristics and performance of a new hs-cTnI method: a multicenter-study
    Tommaso Fasano, Antonio Fortunato, Greta Giacomini, Alberto Aimo, Marco Moretti, Valentina Viola, Jacopo Sabbatinelli, Giorgia Farneti, Paolo Maltoni, Rino Biguzzi et al. · 2025 · Clinical Chemistry and Laboratory Medicine (CCLM)
89. Umbilical cord-derived mesenchymal stromal cells: Promising therapy for heart failure
    Yalun Li, Enguo Chen, Bing-Bing Ren · 2025 · World Journal of Cardiology
90. Cardiovascular Effects of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
    Milene Vitória Sampaio Sobral, Livia Kneipp Rodrigues, Abner Mácola Pacheco Barbosa, Naila Camila da Rocha, Isac Ribeiro Moulaz, João Pedro Pereira dos Santos, Bruno de Jesus Silva Oliveira, João Lucas de Magalhães Leal Moreira, Francis Lopes Pacagnelli, Camila Mota Guida · 2025 · American Journal of Cardiovascular Drugs
91. Determining kidney function-specific thresholds for N-terminal pro-B-type natriuretic peptide in heart failure risk prediction among patients with chronic kidney disease: a multicentre, observational, cohort study
    Yi Lu, Junzhe Chen, Ruixuan Chen, Andrew Fanuel Lukwaro, Shiyu Zhou, Yuxin Luo, Sheng Nie, Ying Tang · 2025 · Heart
92. Integrating pre-ablation and post-ablation B-type natriuretic peptide to identify high-risk population for long-term adverse events and arrhythmic recurrence in persistent atrial fibrillation
    Hironori Ishiguchi, Yasuhiro Yoshiga, Masakazu Fukuda, Shohei Fujii, Masahiro Hisaoka, Shintaro Hashimoto, Takuya Omuro, Noriko Fukue, Shigeki Kobayashi, Motoaki Sano · 2025 · Open Heart
93. Inhibition of Egr2 Protects against TAC-induced Heart Failure in Mice by Suppressing Inflammation and Apoptosis Via Targeting Acot1 in Cardiomyocytes
    Xiaolu Hou, Guo-ling Hu, Heling Wang, Ying Yang, Qi Sun, Xiuping Bai · 2025 · Journal of Cardiovascular Translational Research
94. Association between urinary sodium-to-potassium ratio and BNP in a general population without antihypertensive treatment and cardiovascular diseases: the Ohasama study
    Tomoko Muroya, Michihiro Satoh, Hirohito Metoki, Shingo Nakayama, Takuo Hirose, Takahisa Murakami, Yukako Tatsumi, Ryusuke Inoue, Megumi Tsubota‐Utsugi, Azusa Hara et al. · 2025 · Hypertension Research
95. Independent and combined associations of high-density lipoprotein cholesterol-modified triglyceride-glucose index with all-cause and cardiovascular mortality in patients with acute decompensated heart failure
    Shiming He, Lin Xie, Guobo Xie, Guoan Jian, Kun Jiang, Zhihong Lu, Shuhua Zhang, Qun Wang, Hengcheng Lu, Zhiyu Xiong et al. · 2025 · Frontiers in Endocrinology
96. Beyond volumes and ejection fraction: practical insights into cine-CMR interpretation and applications
    André Vaz, Vinícius Cardoso Serra, Danilo de Oliveira Santana Ramos · 2025 · The International Journal of Cardiovascular Imaging
97. Study Protocol for HeartMagic: A Prospective Observational Cohort Characterizing Subtypes of Heart Failure With Preserved Ejection Fraction
    Philippe Meyer, Angela Rocca, Jaume Banús, Augustin C.C. Ogier, Costa Georgantas, Pauline Calarnou, Anam Fatima, Jean‐Paul Vallée, Jean‐François Deux, Aurélien Thomas et al. · 2025 · Journal of the American Heart Association
98. Life-Space Activities Are Associated with the Prognosis of Older Adults with Cardiovascular Disease
    Kakeru Hashimoto, Akihiro Hirashiki, Koharu Oya, Junpei Sugioka, Shunya Tanioku, Kenji Sato, Ikue Ueda, Naoki Itoh, Manabu Kokubo, Atsuya Shimizu et al. · 2022 · Journal of Cardiovascular Development and Disease
99. Acute heart failure associated with toxic shock syndrome due to methicillin-susceptible Staphylococcus aureus during the postpartum period: case report and systematic literature review
    Takahiro Suzuki, Takahiro Matsuo, Yasufumi Kijima, Ryo Hasegawa, Kazuhiro Ishikawa, Michiko Yamanaka, Fujimi Kawai, Nobuyuki Komiyama, Nobuyoshi Mori · 2022 · BMC Cardiovascular Disorders
100. Clinical Outcomes by Consolidation of Bone Marrow Stem Cell Therapy and Coronary Artery Bypass Graft in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-analysis
     Yinhao Jiang, Ziying Yang, Lianbo Shao, Han Shen, Xiaomei Teng, Yihuan Chen, Yinglong Ding, Jiaming Fan, Yu You, Zhenya Shen · 2023 · Cell Transplantation